drugset / Trial / NCT00151450

Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

NCT00151450

Phase 3 Completed 390 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare pregabalin to Venlafaxine XR and placebo in the treatment of generalized anxiety disorder.

Timeline

Start
2005-03
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 300 mg
Subject Pregabalin Small molecule 600 mg
Subject Venlafaxine Small molecule 75 mg
Subject Venlafaxine Small molecule 225 mg

Indications